Synthetic archaeosome adjuvants for improved vaccine formulation (L-11784) .: NR16-172/2017E-PDF
“Vaccine adjuvants are immune stimulating compounds that, when combined with antigens, enhance the magnitude, the quality and/or the duration of immune responses. Though adjuvants play a central role in vaccination, few non-toxic adjuvants are currently available to vaccine developers. To address this need, the NRC has developed synthetic archaeal lipids for the production of well-defined, tailor-made, non-toxic and thermostable adjuvants that can be can combined with a wide range of antigens. The NRC’s synthetic archaeosomes have both immunomodulating and antigen-delivery adjuvant properties. They can be customized to evoke specific immune responses that are long and durable”--Highlights.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.847509&sl=0
| Department/Agency | National Research Council Canada. |
|---|---|
| Title | Synthetic archaeosome adjuvants for improved vaccine formulation (L-11784) . |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Adjuvants d’archéosomes synthétiques pour améliorer la préparation de vaccins (L-11784). Caption title. "January 2017." Issued also in print format. |
| Publishing information | [Ottawa] : National Research Council Canada, [2018] |
| Description | [1] p. |
| ISBN | 9780660239293 |
| Catalogue number |
|
| Subject terms | Immunological adjuvants Liposomes |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: